ID   MBT-2V
AC   CVCL_VL61
SY   MBT-2 variant
DR   Wikidata; Q95985633
RX   PubMed=16140114;
RX   PubMed=29732388;
CC   Characteristics: High metastatic potential.
CC   Characteristics: Established from a lung metastasis nodule in C3H mice implanted with MBT-2 cells in the leg muscles.
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4660 ! MBT-2
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=16140114; DOI=10.1016/j.urology.2005.03.073;
RA   Horinaga M., Fukuyama R., Nishiyama T., Harsch K.M., Cicek M.,
RA   Heston W., Sizemore N., Casey G., Larchian W.A.;
RT   "Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer
RT   cells.";
RL   Urology 66:676-681(2005).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//